Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_assertion type Assertion NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_head.
- NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_assertion description "[AVI-4126, a neutral antisense phosphorodiamidate morpholino oligomer (PMO) has been identified to specifically inhibit c-MYC expression in multiple disease models and identified in Phase I clinical studies to be safe and bioavailable in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_provenance.
- NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_assertion evidence source_evidence_literature NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_provenance.
- NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_assertion SIO_000772 18096271 NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_provenance.
- NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_assertion wasDerivedFrom befree-20150227 NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_provenance.
- NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_assertion wasGeneratedBy ECO_0000203 NP581804.RApx0Odnf6CStawzA1jujrb0ExGlSm6AQ3LI4gO0gHW1Y130_provenance.